An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer

被引:43
|
作者
Shui, Ruohong [1 ,2 ]
Yu, Baohua [1 ,2 ]
Bi, Rui [1 ,2 ]
Yang, Fei [1 ,2 ]
Yang, Wentao [1 ,2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 05期
关键词
LABELING INDEX; INTERNATIONAL KI67; PROLIFERATION; KI-67; METAANALYSIS; PROGNOSIS; ACCURACY; MARKER;
D O I
10.1371/journal.pone.0125131
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ki67 labeling index (LI) is used as a predictive marker and is associated with prognosis in breast cancer. However, standardised methodologies for measurement are lacking which has limited its application in clinical practice. In this study, we evaluated the interobserver concordance of visual assessment of Ki67 LI in breast cancer. Methods Ki67-immunostained slides of 160 cases of primary invasive breast cancer were visual assessed by five breast pathologists with two different methods to choose the scoring fields: (1) hot-spot score, (2) average score. Proportions of positive invasive tumor cells at 10 % intervals were scored. The intra-class correlation coefficient (ICC) was used to assess the interobserver reproducibility. Results (1) A perfect concordance of Ki67 LI was demonstrated according to both score methods (P<0.0001). Average score method (ICC, 0.904) demonstrated a better correlation than hotspot score method (ICC, 0.894). (2) By respective means according to two score methods, all cases were classified into three groups (<= 10%, 11%-30% and >30% Ki-67 LI). The concordance was relatively low in intermediate Ki67 LI group compared with low and high Ki67 LI groups. (3) All cases were classified into three groups by paired-difference (d) between means of hot-spot score and average score (d<5, 5 <= d<10, d >= 10). The consistency was observed to decrease with increasing paired-difference according to both methods. Conclusions Visual assessment of Ki67 LI at 10% intervals is a candidate for a standard method in breast cancer clinical practice. Average score and hot-spot score of visual assessment both demonstrated a perfect concordance, and an overall average assessment across the whole section including hot spots may be a better method. Interobserver concordance of intermediate Ki67 LI in which most cutoffs are located for making clinical decisions was relatively low.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Ki67 Immunohistochemistry Quantification in Breast Carcinoma: A Comparison of Visual Estimation, Counting, and ImmunoRatio
    van den Berg, Eunice J.
    Duarte, Raquel
    Dickens, Caroline
    Joffe, Maureen
    Mohanlal, Reena
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (02) : 105 - 111
  • [32] Ki67 and Salivary Cancer
    Ben-Izhak, Ofer
    Akrish, Sharon
    Nagler, Rafael M.
    CANCER INVESTIGATION, 2008, 26 (10) : 1015 - 1023
  • [33] Ki67 measured in metastatic tissue and prognosis in patients with advanced breast cancer
    Claudette Falato
    Julie Lorent
    Edneia Tani
    Eva Karlsson
    Paul K. Wright
    Jonas Bergh
    Theodoros Foukakis
    Breast Cancer Research and Treatment, 2014, 147 : 407 - 414
  • [34] Comparative validation of the SP6 antibody to Ki67 in breast cancer
    Zabaglo, Lila
    Salter, Janine
    Anderson, Helen
    Quinn, Emma
    Hills, Margaret
    Detre, Simone
    A'Hern, Roger
    Dowsett, Mitch
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (09) : 800 - 804
  • [35] The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer
    Christgen, Matthias
    von Ahsen, Sabrina
    Christgen, Henriette
    Laenger, Florian
    Kreipe, Hans
    HUMAN PATHOLOGY, 2015, 46 (09) : 1341 - 1349
  • [36] Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer
    Besusparis, Justinas
    Plancoulaine, Benoit
    Rasmusson, Allan
    Augulis, Renaldas
    Green, Andrew R.
    Ellis, Ian O.
    Laurinaviciene, Aida
    Herlin, Paulette
    Laurinavicius, Arvydas
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [37] The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
    Eshwaraiah, Mallikarjuna Siraganahalli
    Gunda, Aparna
    Kanakasetty, Govind Babu
    Bakre, Manjiri M.
    CANCER MEDICINE, 2023, 12 (12): : 13342 - 13351
  • [38] A simple digital image analysis system for automated Ki67 assessment in primary breast cancer
    Alataki, Anastasia
    Zabaglo, Lila
    Tovey, Holly
    Dodson, Andrew
    Dowsett, Mitch
    HISTOPATHOLOGY, 2021, 79 (02) : 200 - 209
  • [39] Visual and digital assessment of Ki-67 in breast cancer tissue-a comparison of methods
    Skjervold, Anette H.
    Pettersen, Henrik Sahlin
    Valla, Marit
    Opdahl, Signe
    Bofin, Anna M.
    DIAGNOSTIC PATHOLOGY, 2022, 17 (01)
  • [40] Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis
    Gallardo, Alberto
    Garcia-Valdecasas, Barbara
    Murata, Paola
    Teran, Rolando
    Lopez, Laura
    Barnadas, Agusti
    Lerma, Enrique
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (01) : 31 - 37